A critical appraisal of the malformation risks following pregabalin use in early pregnancy

ENTIS affiliated researchers from the UK, Denmark and Israel have published a literature review and critical appraisal which explores whether recent SmPC updates applied to some pregabalin products are justified, and provides clarity on the risk-benefit balance for pregabalin use in early pregnancy. This publication was developed after the ENTIS Board and Scientific Committee submitted an official communication to the EMA […]

» Read more

Use of calcium-based antacids and PPIs during pregnancy not found to reduce the risk of late-onset preeclampsia

A collaborative of researchers from Radboud University Medical Center, the Netherlands Pharmacovigilance Centre Lareb and Maastricht University, led by ENTIS associate member Dr Marleen van Gelder, have published a prospective comparative cohort study investigating preeclampsia risk among women exposed to calcium-based antacids and PPIs during pregnancy. More information can be found here. Photo by Mufid Majnun on Unsplash

» Read more

Antidepressant use in pregnancy and the risk of neurodevelopment disorders in children

A collaborative of researchers from Harvard University, Stanford University, Northwestern University (Chicago), University of Pittsburgh, and Brown University have published a large observational cohort study nested in the Medicaid Analytic eXtract and the IBM MarketScan Research Database investigating associations between antidepressant use in pregnancy and neurodevelopmental outcomes in children. The study results suggested up to a doubling in risk of […]

» Read more
1 5 6 7 8 9 23